Medcare unveils AI
technology to spot heart
disease before it even
begins
(DUBAI)
-
Medcare has introduced a
groundbreaking AI-powered
blood test in response to
the growing number of young
people in the region having
cardiovascular issues and
sudden onset of heart
attacks. Clinical studies
show that in the MENA and
South Asia regions, the
average age for a first-time
heart attack has decreased
by 5-10 years. This new
blood test can predict the
development of coronary
artery disease with 95%
accuracy, before there are
any symptoms. Available at
Medcare Hospital Al Safa,
this test is a breakthrough
in preventive cardiology,
offering patients and
physicians a highly
accurate, low-risk and fast
alternative to traditional
diagnostics.
Heart
diseases can be
asymptomatic, showing no
signs until something
serious like a heart attack
happens. In the UAE, this is
becoming evident in younger
people. Research indicates
individuals in this region
are diagnosed with coronary
artery disease about 15
years earlier than in other
countries.
"The
launch of Cardio Explorer
is
a game-changer for early
intervention," said
Dr. Brajesh Mittal Head of
Cardiology Department at
Medcare Hospital Al Safa.
"It allows us to intervene
much earlier, often before
the first warning signs.
This improves our ability to
detect coronary artery
disease at a stage where we
can still make a significant
difference through early
treatment and lifestyle
changes."
One of the
technologies is a
CE-certified AI algorithm
developed in Europe to
analyse a combination of
blood biomarkers, clinical
parameters (like age and
blood pressure), and
individual risk factors.
After a simple blood draw
and recording of key
metrics, results are
delivered within 48–72
hours, reviewed by a
cardiologist, and translated
into a personalized heart
risk score. The system
delivers a personalized
heart risk score with 95%
diagnostic accuracy,
comparable to CT angiography
and cardiac MRI, but without
the need for radiation or
physical exertion. This
makes it especially
beneficial for individuals
who have known risk factors
like high blood pressure,
diabetes, or a family
history of heart disease. It
is also an ideal option for
patients who cannot undergo
traditional stress tests or
imaging due to their age,
other health issues, or
implanted cardiac devices.
Dr. Ghassan
Nakad, Specialist
Interventional Cardiology,
Medcare Hospital Al Safa,
said, "What sets
this test apart is its
simplicity, safety, and
proven clinical value. It
avoids invasive procedures
and radiation exposure, yet
delivers accurate,
actionable insights. For
patients with known risk
factors like high blood
pressure, diabetes or a
family history of
cardiovascular diseases, it
offers either peace of mind
or an early window for
intervention."
According to worldwide data,
Dr. Nakad noted that young
people experiencing heart
attacks make up 10-30% of
all heart attack admissions,
varying by region. “At
Medcare hospitals, and in
the UAE, we have seen that
around 50% of our cardiac
patients are under 50. Last
year, out of 11,631 patients
visiting our cardiology
outpatient departments
within the Medcare network,
9,817 were 45 or younger.
Cardiac conditions were
suspected in 30% of these
younger patients, leading to
detailed testing. About 3%
were diagnosed with serious
heart issues that needed
more treatments”.
“It
is quite shocking that this
is close to older patients,
where 46% had detailed
testing and about 5% needed
treatment. Sadly, young
people are catching up to
older people when it comes
to age-related diseases,
with heart issues starting
sooner. Global reports show
that in the Middle East,
North Africa, and South
Asia, the average age for a
first heart attack has
dropped by 5-10 years. UAE
residents, on average, are
seeing coronary artery
disease 15 years earlier
than people in other
countries”, he explained.
Cardio Explorer is
especially valuable for
individuals with risk
profiles that include a
sedentary lifestyle,
smoking, or early symptoms
such as unexplained fatigue,
mild chest discomfort or
shortness of breath. It
offers a cost-effective,
low-risk way to stratify
patients before they develop
advanced disease.
Dr. Yogeswari
Vellore Satyanarayanan,
Specialist Cardiology,
Medcare Royal Speciality
Hospital, Al Qusais, and
Medcare Hospital Sharjah
said, “AI holds the
promise of democratizing
heart care. AI’s ability to
combine complex biological
data promises to redefine
how we classify heart
diseases, discover new
biomarkers, and design safer
therapies.
Medcare
Hospitals & Medical Centres
is also expanding their
scope within interventional
cardiology, advancing with
the latest state-of-the-art
Cath Lab in Medcare Sharjah,
as well as super specialized
services such as the Smart
Heart Failure clinic,
pulmonary hypertension and
cardio obstetrics services.
By offering a
proactive, non-invasive way
to detect significant
coronary artery disease
early, Medcare Hospital Al
Safa reinforces its
leadership in
forward-thinking cardiac
care. Cardio Explorer sets a
new benchmark in early
detection, empowering
patients to take charge of
their heart health before
it's too late.
PRINT
THIS ARTICLE
|